为什么伊朗的艾滋病毒/艾滋病患病率上升了？ - Suppr

Suppr

超能文献

Why Has HIV/AIDS Prevalence Increased in Iran?

作者信息

Heidary Mohsen, Nasiri Mohammad Javad

机构信息

Department of Medical Microbiology, Iran University of Medical Sciences.

Department of Medical Microbiology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Clin Infect Dis. 2016 Sep 15;63(6):846. doi: 10.1093/cid/ciw361. Epub 2016 Jun 9.

DOI:10.1093/cid/ciw361

PMID:27282708

Abstract

摘要

相似文献

Why Has HIV/AIDS Prevalence Increased in Iran?

Clin Infect Dis. 2016 Sep 15;63(6):846. doi: 10.1093/cid/ciw361. Epub 2016 Jun 9.

HIV, stigma, and rates of infection: more complicated than Reidpath and Chan suggest.

PLoS Med. 2007 Jan;4(1):e51; author reply e44. doi: 10.1371/journal.pmed.0040051.

HIV/AIDS harm reduction in Iran.

Lancet. 2006 Aug 5;368(9534):434-5. doi: 10.1016/S0140-6736(06)69132-0.

Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran.

Int J Drug Policy. 2010 Nov;21(6):493-500. doi: 10.1016/j.drugpo.2010.04.006. Epub 2010 May 18.

Injecting drug use, HIV and AIDS.

AIDS Care. 1989;1(3):237-45. doi: 10.1080/09540128908253029.

HIV risk behaviors of heterosexual male drug users.

NIDA Res Monogr. 1994;143:5-8.

Social networks in disease transmission: the Colorado Springs Study.

NIDA Res Monogr. 1995;151:3-19.

A comparison of drug use networks across three cities.

NIDA Res Monogr. 1995;151:109-30.

HIV/AIDS epidemic features and trends in Iran, 1986-2006.

AIDS Behav. 2009 Apr;13(2):297-302. doi: 10.1007/s10461-008-9452-7. Epub 2008 Sep 4.

Emergent properties of HIV risk among injection drug users in Tallinn, Estonia: synthesis of individual and neighbourhood-level factors.

Sex Transm Infect. 2010 Dec;86 Suppl 3:iii79-84. doi: 10.1136/sti.2009.040212.

引用本文的文献

An application of social marketing for promoting HIV testing in Iran.

BMC Public Health. 2023 May 11;23(1):865. doi: 10.1186/s12889-023-15698-5.

The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic.

Front Public Health. 2022 Dec 21;10:1025633. doi: 10.3389/fpubh.2022.1025633. eCollection 2022.

Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019.

Lancet. 2022 Apr 23;399(10335):1625-1645. doi: 10.1016/S0140-6736(21)02751-3. Epub 2022 Apr 6.

Clinical Characteristics, Diagnosis, Treatment, and Mortality Rate of TB/COVID-19 Coinfectetd Patients: A Systematic Review.

Front Med (Lausanne). 2021 Dec 1;8:740593. doi: 10.3389/fmed.2021.740593. eCollection 2021.

Investigating the effect of education on man immunodeficiency virus/acquired immune deficiency syndrome preventive behaviors in vulnerable women living in peripheral neighborhoods: Applications of the health belief model.

J Educ Health Promot. 2020 Nov 26;9:302. doi: 10.4103/jehp.jehp_325_20. eCollection 2020.

Quality Of Life And Stigma Among People Living With HIV/AIDS In Iran.

HIV AIDS (Auckl). 2019 Nov 12;11:287-298. doi: 10.2147/HIV.S221512. eCollection 2019.

High genetic diversity among strains in Tehran, Iran.

J Clin Tuberc Other Mycobact Dis. 2018 Jan 31;11:1-6. doi: 10.1016/j.jctube.2018.01.001. eCollection 2018 May.

Comprehensive analysis of the HIV/AIDS policy-making process in Iran.

Health Res Policy Syst. 2019 Jul 19;17(1):69. doi: 10.1186/s12961-019-0466-6.

Primary bilateral non-Hodgkin's lymphoma of the adrenal gland.

Indian J Urol. 2019 Apr-Jun;35(2):173-174. doi: 10.4103/iju.IJU_359_18.

Infections in Iran.

New Microbes New Infect. 2018 Oct 25;27:7-8. doi: 10.1016/j.nmni.2018.10.007. eCollection 2019 Jan.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Why Has HIV/AIDS Prevalence Increased in Iran?

Clin Infect Dis. 2016 Sep 15;63(6):846. doi: 10.1093/cid/ciw361. Epub 2016 Jun 9.

HIV, stigma, and rates of infection: more complicated than Reidpath and Chan suggest.

PLoS Med. 2007 Jan;4(1):e51; author reply e44. doi: 10.1371/journal.pmed.0040051.

HIV/AIDS harm reduction in Iran.

Lancet. 2006 Aug 5;368(9534):434-5. doi: 10.1016/S0140-6736(06)69132-0.

Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran.

Int J Drug Policy. 2010 Nov;21(6):493-500. doi: 10.1016/j.drugpo.2010.04.006. Epub 2010 May 18.

Injecting drug use, HIV and AIDS.

AIDS Care. 1989;1(3):237-45. doi: 10.1080/09540128908253029.

HIV risk behaviors of heterosexual male drug users.

NIDA Res Monogr. 1994;143:5-8.

Social networks in disease transmission: the Colorado Springs Study.

NIDA Res Monogr. 1995;151:3-19.

A comparison of drug use networks across three cities.

NIDA Res Monogr. 1995;151:109-30.

HIV/AIDS epidemic features and trends in Iran, 1986-2006.

AIDS Behav. 2009 Apr;13(2):297-302. doi: 10.1007/s10461-008-9452-7. Epub 2008 Sep 4.

Emergent properties of HIV risk among injection drug users in Tallinn, Estonia: synthesis of individual and neighbourhood-level factors.

Sex Transm Infect. 2010 Dec;86 Suppl 3:iii79-84. doi: 10.1136/sti.2009.040212.

引用本文的文献

An application of social marketing for promoting HIV testing in Iran.

BMC Public Health. 2023 May 11;23(1):865. doi: 10.1186/s12889-023-15698-5.

The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic.

Front Public Health. 2022 Dec 21;10:1025633. doi: 10.3389/fpubh.2022.1025633. eCollection 2022.

Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019.

Lancet. 2022 Apr 23;399(10335):1625-1645. doi: 10.1016/S0140-6736(21)02751-3. Epub 2022 Apr 6.

Clinical Characteristics, Diagnosis, Treatment, and Mortality Rate of TB/COVID-19 Coinfectetd Patients: A Systematic Review.

Front Med (Lausanne). 2021 Dec 1;8:740593. doi: 10.3389/fmed.2021.740593. eCollection 2021.

J Educ Health Promot. 2020 Nov 26;9:302. doi: 10.4103/jehp.jehp_325_20. eCollection 2020.

Quality Of Life And Stigma Among People Living With HIV/AIDS In Iran.

HIV AIDS (Auckl). 2019 Nov 12;11:287-298. doi: 10.2147/HIV.S221512. eCollection 2019.

High genetic diversity among strains in Tehran, Iran.

J Clin Tuberc Other Mycobact Dis. 2018 Jan 31;11:1-6. doi: 10.1016/j.jctube.2018.01.001. eCollection 2018 May.

Comprehensive analysis of the HIV/AIDS policy-making process in Iran.

Health Res Policy Syst. 2019 Jul 19;17(1):69. doi: 10.1186/s12961-019-0466-6.

Primary bilateral non-Hodgkin's lymphoma of the adrenal gland.

Indian J Urol. 2019 Apr-Jun;35(2):173-174. doi: 10.4103/iju.IJU_359_18.

Infections in Iran.

New Microbes New Infect. 2018 Oct 25;27:7-8. doi: 10.1016/j.nmni.2018.10.007. eCollection 2019 Jan.